Sho SATO - Papers - researchmap

Adjuvant chemotherapy in patients with uterine carcinosarcoma: a review of clinical outcomes and considerations.

Ogasawara A, Shintani D, Sato S, Hasegawa K

Expert Opinion on Orphan Drugs, 9 11-12, 2021 Peer-reviewedInvitedLast author

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.

Yuji Ikeda, Sho Sato, Akira Yabuno, Daisuke Shintani, Aiko Ogasawara, Maiko Miwa, Makda Zewde, Takashi Miyamoto, Keiichi Fujiwara, Yusuke Nakamura …

J Gynecol Oncol, 31(6) e93, Aug 24, 2020 Peer-reviewedLead author

Daisuke Shintani, Taro Hihara, Aiko Ogasawara, Sho Sato, Akira Yabuno, Kenji Tai, Keiichi Fujiwara, Keisuke Watanabe, ◎Kosei Hasegawa

Int J Gynecol Cancer, 30(9) 1340-1346, Jul 21, 2020 Peer-reviewed

Current and future strategies for treatment of ovarian clear cell carcinoma

Aiko Ogasawara, Sho Sato, ◎Kosei Hasegawa

Journal of Obstetrics and Gynaecology Research, 46(9) 1678-1689, Jun 23, 2020 Peer-reviewedInvitedLead author

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.

Hirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda, Shogo Yamamoto, Kayo Asada, Takahiro Karasaki, Akira Yabuno, Akira Nishijima, Takahide Nejo, Yukari Kobayashi …

J Immunother Cancer ., 8(1) e000375, May 7, 2020 Peer-reviewed

Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy.

Tatsuya Hanaoka, Kosei Hasegawa, Tomomi Kato, Sho Sato, Akira Kurosaki, Akiko Miyara, Shoji Nagao, Hiroyuki Seki, Masanori Yasuda, Keiichi Fujiwara

Molecular diagnosis & therapy, 21(2) 187-198, Apr, 2017 Peer-reviewed

悪性転化を伴う卵巣成熟嚢胞性奇形腫の4例

Apr, 2016 Peer-reviewedLead author

Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass.

Tomonori Nagai, Yasushi Takai, Taichi Akahori, Hiroaki Ishida, Tatsuya Hanaoka, Takahiro Uotani, Sho Sato, Shigetaka Matsunaga, Kazunori Baba, Hiroyuki Seki

SpringerPlus, 4 520-520, 2015 Peer-reviewed

Concomitant sentinel lymph node biopsy leading to abbreviated systematic lymphadenectomy in a patient with primary malignant melanoma of the vagina.

Hiroaki Ishida, Tomonori Nagai, Syo Sato, Michiko Honda, Takahiro Uotani, Kouki Samejima, Tatsuya Hanaoka, Taichi Akahori, Yasushi Takai, Hiroyuki Seki

SpringerPlus, 4 102-102, 2015 Peer-reviewed

Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass.

Tomonori Nagai, Yasushi Takai, Taichi Akahori, Hiroaki Ishida, Tatsuya Hanaoka, Takahiro Uotani, Sho Sato, Shigetaka Matsunaga, Kazunori Baba, Hiroyuki Seki

SpringerPlus, 3 678-678, 2014 Peer-reviewed